Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2022

Open Access 01-12-2022 | Esophageal Cancer | Case report

Fatal noncardiogenic pulmonary edema related to nonionic, iso-osmolar iodine contrast medium: one case report

Authors: Kun-ming Yi, Xue Li

Published in: BMC Pulmonary Medicine | Issue 1/2022

Login to get access

Abstract

Background

Noncardiogenic pulmonary edema (NCPE) is a rare and life-threatening allergy-like reaction to the intravascular injection of a nonionic radiographic agent. We first describe a very rare case of fatal NCPE after the intravenous injection of nonionic, iso-osmolar iodine contrast media.
Case presentation
A 55-year-old male patient was admitted to the hospital with esophageal cancer. After the intravenous administration of 100 mL iodixanol, the patient first exhibited digestive tract symptoms, including abdominal pain, diarrhea, and vomiting, with no dyspnea, rash, itching, or throat edema. He received anti-allergy treatment, but his symptoms did not improve; instead, he further developed pulmonary edema. Arterial blood gas analysis results were as follows: pH, 7.08; PO2, 70 mm Hg; PCO2, 40 mm Hg; and SaO2, 52%. Then, the patient received emergent tracheal intubation and ventilation to assist breathing, and he was transferred to the intensive care unit (ICU) for further treatment. In the ICU, the patient developed shock and respiratory and circulatory failure; therefore, he received shock resuscitation, acidosis correction, muscle relaxants to lower the work of breathing, and cardiotonic therapy. The patient eventually died. During the ICU period, emergency bedside color ultrasound showed a diffuse B line in both lungs, and the size of the cardiac cavity was normal, but the ventricular rate was extremely fast. Chest radiography showed pulmonary edema with a normal cardiac silhouette, and the brain natriuretic peptide (BNP) level was in the normal range.

Conclusions

NCPE is a rare and critical allergy-like reaction to the use of a nonionic iso-osmolar radiocontrast contrast medium. Clinicians should pay very close attention to digestive tract manifestations during the medical observation of patients, as gastrointestinal manifestations may be the prodromal symptoms of NCPE caused by iso-osmolar contrast medium injection.
Literature
1.
go back to reference Hauggaard A. Non-cardiogenic pulmonary oedema after intravenous administration of non-ionic contrast media. Acta Radiol. 1996;37(5):823–5.CrossRef Hauggaard A. Non-cardiogenic pulmonary oedema after intravenous administration of non-ionic contrast media. Acta Radiol. 1996;37(5):823–5.CrossRef
2.
go back to reference Paul RE, George G. Fatal non-cardiogenic pulmonary oedema after intravenous non-ionic radiographic contrast. Lancet. 2002;359(9311):1037–8.CrossRef Paul RE, George G. Fatal non-cardiogenic pulmonary oedema after intravenous non-ionic radiographic contrast. Lancet. 2002;359(9311):1037–8.CrossRef
3.
go back to reference Pincet L, Lecca G. Acute pulmonary edema induced by non-ionic low-osmolar radiographic contrast media. Open Access Emerg Med. 2018;10:75–9.CrossRef Pincet L, Lecca G. Acute pulmonary edema induced by non-ionic low-osmolar radiographic contrast media. Open Access Emerg Med. 2018;10:75–9.CrossRef
4.
go back to reference Kang MH, Nah JC. A delayed, unusual non-cardiogenic pulmonary edema after intravascular administration of non-ionic, low osmolar radiocontrast media for coronary angiography. Korean Circ J. 2013;43(7):500–3.CrossRef Kang MH, Nah JC. A delayed, unusual non-cardiogenic pulmonary edema after intravascular administration of non-ionic, low osmolar radiocontrast media for coronary angiography. Korean Circ J. 2013;43(7):500–3.CrossRef
5.
go back to reference Morcos SK. Review article. Effects of radiographic contrast media on the lung. Br J Radiol. 2003;76(905):290–5.CrossRef Morcos SK. Review article. Effects of radiographic contrast media on the lung. Br J Radiol. 2003;76(905):290–5.CrossRef
6.
go back to reference Pasternak JJ, Williamson EE. Clinical pharmacology, uses, and adverse reactions of iodinated contrast agents: a primer for the non-radiologist. Mayo Clin Proc. 2012;87(4):390–402.CrossRef Pasternak JJ, Williamson EE. Clinical pharmacology, uses, and adverse reactions of iodinated contrast agents: a primer for the non-radiologist. Mayo Clin Proc. 2012;87(4):390–402.CrossRef
7.
go back to reference Schopp JG, Iyer RS, Wang CL, Petscavage JM, Paladin AM, Bush WH, et al. Allergic reactions to iodinated contrast media: premedication considerations for patients at risk. Emerg Radiol. 2013;20(4):299–306.CrossRef Schopp JG, Iyer RS, Wang CL, Petscavage JM, Paladin AM, Bush WH, et al. Allergic reactions to iodinated contrast media: premedication considerations for patients at risk. Emerg Radiol. 2013;20(4):299–306.CrossRef
8.
go back to reference Kemp SF, Lockey RF, Simons FE. Epinephrine: the drug of choice for anaphylaxis a statement of the World Allergy Organization. Allergy. 2008;63(8):1061–70.CrossRef Kemp SF, Lockey RF, Simons FE. Epinephrine: the drug of choice for anaphylaxis a statement of the World Allergy Organization. Allergy. 2008;63(8):1061–70.CrossRef
9.
go back to reference Guru PK, Bohman JK, Fleming CJ, Tan HL, Sanghavi DK, Moraes AG, et al. Severe acute cardiopulmonary failure related to gadobutrol magnetic resonance imaging contrast reaction: successful resuscitation with extracorporeal membrane oxygenation. Mayo Clin Proc. 2016;91(3):362–6.CrossRef Guru PK, Bohman JK, Fleming CJ, Tan HL, Sanghavi DK, Moraes AG, et al. Severe acute cardiopulmonary failure related to gadobutrol magnetic resonance imaging contrast reaction: successful resuscitation with extracorporeal membrane oxygenation. Mayo Clin Proc. 2016;91(3):362–6.CrossRef
Metadata
Title
Fatal noncardiogenic pulmonary edema related to nonionic, iso-osmolar iodine contrast medium: one case report
Authors
Kun-ming Yi
Xue Li
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2022
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-022-01908-0

Other articles of this Issue 1/2022

BMC Pulmonary Medicine 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.